XAVFLI O’SMALARNI DAVOLASHDA BRAXITERAPIYANING ROLI VA DOLZARBLIGI
Keywords:
Kalit so'zlar: braxiterapiya, masofaviy nur terapiya, braxi-bustAbstract
Annotatsiya: Nur terapiya monorejim yoki boshqa davolash usullari bilan
birgalikda xavfli o'smalari bo'lgan bemorlarning 70% dan ortig'ida amalga oshiriladi.
Radiatsiya manbasining joylashishiga qarab, nur terapiyasi masofaviy va
braxiterapiyaga bo'linadi. Braxiterapiya masofadan ta'sir qilish usuliga nisbatan katta
afzalliklarga ega: u o'smaning siljishini tekislaydi, qo'shni organlarga doza yukini
kamaytiradi, nur terapiyasini iloji boricha tez va aniq amalga oshirishni ta'minlaydi,
tomoterapiya va proton terapiyasi kabi boshqa yuqori aniqlikdagi mahalliy ta'sir qilish
usullariga qaraganda ancha arzonroqdir. Braxiterapiya mustaqil rejimda ham,
masofaviy nur terapiyasi bilan birgalikda ham qo'llaniladi. Onkoginekologik
bemorlarni davolashda braxiterapiya "oltin standart" dir. U prostata bezi saratoni bilan
og'rigan bemorlarni davolashda ham qo'llaniladi va radikal prostatektomiyaning
muqobil usuli hisoblanadi. Braxiterapiya periorbital soxada, burun va quloq tog’ayida
joylashgan melanom bo'lmagan xavfli teri o'smalari bilan og'rigan bemorlarni
davolashda eng yaxshi terapevtik usul hisoblanadi, chunki jarrohlik aralashuvlar har
doim ham qoniqarli estetik va funktsional natijalarga olib kelmaydi. Braxiterapiya
qizilo'ngach saratoni, bosh va bo'yin o'smalari va boshqa xavfli o’sma kasalliklari bilan
og'rigan bemorlarni davolashda ham qo'llaniladi, bu o'smani mahalliy nazorat
qilishning yuqori ko'rsatkichlarini ta'minlaydi.
References
Foydalanilgan adabiyotlar:
1. Mould R.F. The early history of x-ray diagnosis with emphasis on the
contributions of physics
1895–1915 // Phys. Med. Biol. 1995. Vol. 40. № 11. P. 1741–1787.
2. Henschke U.K., Hilaris B.S., Mahan D.G. Intracavitary radiation therapy of
uterine cancer by
remote afterloading with cycling sources // Amer. J. Roentgenol. 1966. Vol. 96.
P. 45.
3. Herrmann T., Christen N., Alheit HD. Gynecologic brachytherapy – from
low-dose-rate to high-tach
// Strahlenther Onkol. 1993. Vol. 169. № 3. P. 141–151.
4. Joslin C.A. Clinical application of high activity sourse afterloading in the
United Kingd // In: Afterloading: 20 years of expierence. Ed. B.S. Hilaris. – New York.
1975. P. 209–212.
5. Simon N., Silverstone S.M., Roach L.C. An overview of afterloading in
radiotherapy // Amer. J.
Roentgenol. 1972. Vol. 114. P. 646–647.
6. Tanderup K., Menard C., Polgar C., Lindegaard J.C. et al. Advancements in
brachytherapy // Adv. Drug. Deliv. Rev. 2017. Vol. 96. P. 15–25.
7. Gill B.S., Lin J.F., Krivak T.C. et al. National Cancer Data Base analysis of
radiation therapy consolidation modality for cervical cancer: the impact of new
technological advancements // Int. J. Radiat. Oncol. Biol. Phys. 2014. Vol. 90. № 5. P.
1083–1090.
8. Georg D., Kirisits C., Hillbrand M. et al. Image-guided radiotherapy for cervix
cancer: high-tech external beam therapy versus high-tech brachytherapy // Int. J.
Radiat. Oncol. Biol. Phys. 2008. Vol. 71. № 4. P. 1272–1278.
9. Potter R., Haie-Meder C., Van Limbergen E. et al. GEC ESTRO Working
Group. Recommendations
from gynaecological (GYN) GEC ESTRO working group (II): concepts and
terms in 3D image-based
treatment planning in cervix cancer brachytherapy-3D dose volume parameters
and aspects of 3D imagebased anatomy, radiation physics, radiobiology // Radiother.
Oncol. 2006. Vol. 78. № 1. P. 67–77.
10. Tanderup K., Lindegaard J.C., Kirisits C. et al. Image Guided Adaptive
Brachytherapy in Cervix Cancer: A New Paradigm Changing Clinical Practice and
Outcome // Radiother. Oncol. 2016. Vol. 120. № 3. P. 365–369.
11. Sturdza A., Potter R., Fokdal L.U., Haie-Meder C. Image guided
brachytherapy in locally advanced cervical cancer: Improved pelvic control and
survival in RetroEMBRACE, a multicenter cohort study // Radiother. Oncol. 2016.
Vol. 120. № 3. P. 428–433.
12. Fokdal L., Sturdza A., Mazeron R. et al. Image guided adaptive
brachytherapy with combined
intracavitary and interstitial technique improves the therapeutic ratio in locally
advanced cervical
cancer: Analysis from the retroEMBRACE study // Radiother. Oncol. 2016. Vol.
120. № 3. P. 434–440.
13. Georg P., Lang S., Dimopoulos J.C. et al. Dose–volume histogram
parameters and late side effects in
magnetic resonance image-guided adaptive cervical cancer brachytherapy // Int.
J. Radiat. Oncol. Biol. Phys. 2011. Vol. 79. № 2. P. 356–362.
14. Prescribing, Recording, and Reporting Brachytherapy for Cancer of the
Cervix // J/ ICRU. 2013. Vol. 13. № 1–2:NP.
15. Petric P., Kirisits C. Potential role of TRAns Cervical Endosonography
(TRACE) in brachytherapy of
cervical cancer: proof of concept // J. Contemp. Brachytherapy. 2016. Vol. 8. №
3. P. 215–220.
16. Potter R., Georg P., Dimopoulos J.C., Grimm M. Clinical outcome of
protocol based image (MRI) guided adaptive brachytherapy combined with 3D
conformal radiotherapy with or without chemotherapy in patients with locally
advanced cervical cancer // Radiother. Oncol. 2011. Vol. 100. № 1. P. 116–123.
17. Viswanathan A.N., Thomadsen B. American Brachytherapy Society
consensus guidelines for locally advanced carcinoma of the cervix. Part I: general
principles. American Brachytherapy Society
Cervical Cancer Recommendations Committee, American Brachytherapy
Society // Brachytherapy. 2012. Vol. 11. № 1. P. 33–46.
18. Viswanathan A.N., Beriwal S., De Los Santos J.F. et al. American
Brachytherapy Society consensus guidelines for locally advanced carcinoma of the
cervix. Part II: high-dose-rate brachytherapy // Brachytherapy. 2012. Vol. 11. № 1. P.
47–52.
19. Rijkmans E.C., Nout R.A., Rutten I.H., Ketelaars M. Improved survival of
patients with cervical cancer treated with image-guided brachytherapy compared with
conventional brachytherapy // Gynecol. Oncol. 2014. Vol. 135. № 2. P. 231–8.
20. Гладилина И.А., Шабанов М.А., Федосеенко Д.И. и соавт. Лучевая
терапия больных раком левой молочной железы I–IIA стадии после
органосохраняющих операций // Злокачественные опухоли. 2017. Т. 7. № 4. С. 5–12
